First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. (Q55400645)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. |
scientific article |
Statements
First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. (English)
1 reference
Thomas F Gajewski
1 reference
Peter J O'Dwyer
1 reference
Jason Clark
1 reference
Jack G Shi
1 reference
Kevin J Bowman
1 reference
Peggy A Scherle
1 reference
Robert C Newton
1 reference
Richard Schaub
1 reference
Janet Maleski
1 reference
Lance Leopold
1 reference
4 January 2017
1 reference
23
1 reference
13
1 reference
3269-3276
1 reference
1 reference